Your Strength. Our Knowledge and Experience.

Caring for someone with cancer can make maintaining your own health seem difficult. To effectively care for your loved one, it’s vital to schedule time for your own medical appointments and self-care routines. Prioritizing your health ensures you have the strength and energy to continue providing support. Incorporate self-care practices such as maintaining a balanced diet, getting adequate sleep, engaging in regular physical activity, and practicing relaxation techniques like deep breathing or meditation.

There are resources to help you stay physically active and connected to the world around you. If you need help finding services in your area, contact an EPCC social worker.

The emotional toll of caregiving can lead to feelings of isolation and exhaustion. The following resources can help nurture your emotional well-being and provide strategies for maintaining balance while caring for your loved one.

Our social workers are available to offer counseling and connect you with local support services. To speak with a licensed social worker, contact your nearest EPCC location during business hours.

Important: In case of an emergency, do not leave a message—call 911 directly.

Connecting with others and carving out time for yourself can be difficult. Getting assistance with everyday tasks can free up energy and reduce stress.

• Reducing Stress and Anxiety: Share your feelings with family and friends so they understand your needs. Consider designating one or two people as primary contacts to communicate important updates or coordinate help.
• Organizing Support: Organizing support for cancer patients can make a significant difference in their quality of life and treatment experience. Here are some ideas:

• Create a Care Calendar or Schedule: Use tools like Lotsa Helping Hands or a shared online calendar to coordinate tasks such as meal preparation, transportation, errands, and childcare.
• Designate Support Roles: Assign specific responsibilities to friends or family members—e.g., one person manages appointments, another handles meals, and someone else provides emotional support.
• Use Digital Platforms: Set up a private CaringBridge site or Facebook group for updates, sharing needs, and organizing volunteer efforts.
• Meal Train: Organize a meal delivery schedule through services like MealTrain.com to ensure consistent nutritious meals.
• Transportation Assistance: Coordinate rides to treatment appointments through community programs, local volunteer driver services, or rideshare apps.
• Host Support Groups: Establish or join local or virtual support groups for patients and caregivers to share experiences and advice.
• Organize Practical Help: Arrange for cleaning services, home repairs, or pet care through local providers or community resources.
• Spiritual and Emotional Support: Connect with local chaplain services, spiritual care providers, or mental health counselors who can offer guidance and comfort.
• Fundraising and Resources: Set up crowdfunding campaigns or organize community fundraising events to support medical expenses or related needs.
• Encourage Self-Care and Reflection: Support the patient in incorporating activities like meditation, journaling, or nature walks into their routine, and facilitate access to these resources.

Implementing even a few of these strategies can greatly ease the burden on patients and caregivers, fostering a supportive community around their treatment and recovery.

Resources in Your Area:

• Meal Delivery: Meals on Wheels — check their website for local providers.
• Transportation: Local transportation services in the Central Valley, or the American Cancer Society Road to Recovery (800-227-2345).
• Cleaning Services:
  Modesto:
  MaidPro Modesto — Professional cleaning services including residential and light commercial cleaning.
  Sweet Home Cleaning — Offers regular and deep cleaning options for homes.
  
  Merced:
  Maid in Merced — House cleaning services with flexible scheduling.
  Merced Cleaning Service — Residential cleaning, move-in/move-out cleaning, and special deep cleaning.
  
  Manteca:
  Manteca Cleaning Service — Residential and commercial cleaning, including carpet and upholstery cleaning.
  Simply Clean Manteca — Home cleaning services tailored to your needs.

Please note that it’s advisable to verify current availability, reviews, and insurance coverage before hiring any service.

• Home Care Support: Consult your medical team for referrals suitable to your needs, with local providers available in Modesto, Merced, and Manteca.

Spirituality can mean different things to each person, often related to finding purpose and connection in life. As a caregiver, taking time for reflection and nurturing your spirit is essential but can be overlooked.

Resources and practices such as meditation, guided visualization, journaling, spending time in nature, or connecting with a spiritual care provider can be helpful.

Connecting with Spiritual Support:
Start by contacting your local hospital’s pastoral care or chaplain services. They can connect you with a non-denominational chaplain or spiritual counselor who can offer support and guidance aligned with your beliefs or preferences.

If you need additional assistance or specific resources tailored to your area, please contact a social worker at your EPCC location.

A cancer diagnosis can profoundly impact family dynamics, routines, and relationships. Family members may experience their own emotional stresses, worry about the patient’s health, and take on new caregiving roles. Communication can become more open or strained, and adjusting to changes in roles—such as caregiver, supporter, or decision-maker—requires flexibility and understanding. Supporting the emotional needs of each family member and seeking family counseling or support groups can help the entire family navigate this challenging time together.

Returning to work after cancer treatment often requires adjustments to accommodate ongoing health needs, fatigue, or emotional changes. Many survivors find they need to modify their schedules, work part-time, or explore flexible work arrangements. Open communication with employers about your needs can foster understanding and support. Establishing a new routine that balances recovery with professional responsibilities helps rebuild confidence and maintain a sense of purpose.

Psychological resilience plays a crucial role in survivorship. Many survivors face emotional challenges such as anxiety, depression, or fear of recurrence. Prioritizing mental health through counseling, support groups, mindfulness practices, or relaxation techniques can foster emotional well-being. Recognizing that emotional healing is part of the journey encourages survivors to seek help when needed and to nurture a positive outlook.

During Treatment

Receiving a cancer diagnosis can evoke feelings of shock, fear, anger, or uncertainty. The stress of treatment side effects, hospital visits, and lifestyle changes can lead to anxiety and depression. It is normal to experience a wide range of emotions during this time. Maintaining open communication with your healthcare team about your emotional well-being is essential. Psychological support or counseling can provide tools to manage anxiety, depressive symptoms, and emotional distress.

Surviving Cancer

While completing treatment brings relief, many survivors face ongoing emotional challenges such as fear of recurrence, adapting to physical changes, or reintegrating into daily life. Feelings of vulnerability, grief, or identity shifts are common. Building a support network, engaging in self-care, and participating in survivorship programs can foster resilience and emotional strength. Remember, healing is not only physical but also mental and emotional.

Supporting mental health throughout the cancer journey involves accessing appropriate resources:

• Counseling and Therapy: Licensed mental health professionals, including psychologists and social workers, specialize in addressing cancer-related emotional issues. Sessions can offer coping strategies, emotional processing, and support for anxiety or depression.
• Support Groups: Connecting with others who have similar experiences provides comfort, shared knowledge, and a sense of community. Many organizations offer in-person and virtual support groups for patients and caregivers.
• Mind-Body Techniques: Practices such as meditation, yoga, relaxation exercises, or journaling can reduce stress and promote emotional balance.
• Educational Resources: Learning about common emotional reactions to cancer can normalize your experience and provide helpful coping tips. Many cancer centers and organizations offer educational materials or workshops.
• Emergency Support: If you experience severe depression, thoughts of self-harm, or suicidal feelings, seek immediate help by contacting emergency services or going to the nearest emergency room.

Where to Get Help:

• Talk to your healthcare team about mental health concerns; they can refer you to mental health specialists experienced in oncology.
• Contact local mental health clinics or community organizations offering counseling services.
• Utilize national resources like the American Cancer Society’s Reach To Recovery program or the National Alliance on Mental Illness (NAMI).

Treatment can be demanding, making it easy to forget everyday tasks. To manage this, consider making a list of your daily and weekly responsibilities. Keep a notebook handy to jot down additional tasks as they come to mind. Examples of items to include are:

• Grocery shopping
• Preparing school lunches
• Transportation for children to school and extracurricular activities
• Walking pets
• Meal preparation
• Laundry tasks

Also, create a separate list detailing the support you might need, such as rides to appointments. Utilize tools like calendars or digital apps to stay organized, and feel free to post updates or requests for assistance from friends and family.

Building a reliable support network is vital during your cancer journey. Both emotional and practical support can make a significant difference as you navigate treatment. Friends and family can be invaluable—don’t hesitate to reach out and seek their help. Consider EPCCC’s support groups as a resource to connect with others facing similar challenges. Having additional eyes to help with planning and logistics can alleviate the burden, whether it involves household chores, meal preparation, or transportation. If necessary, hiring a caregiver can provide you with consistent assistance for medication management and activities of daily living.

Remember, asking for help is not a burden; many people genuinely want to support you but might not know how unless you tell them what you need.

Maintaining your mental and physical health is essential during this time.

Prior to starting treatment, focus on nourishing your body with healthy foods and engaging in regular exercise, as permitted. Explore activities that support your mental well-being, such as yoga, meditation, or counseling with a professional. Remember, your emotional state as you enter treatment can significantly impact how you feel during the process, so aim to cultivate healthy habits now.

If chemotherapy is part of your treatment plan, preparing a chemo bag can help ease anxiety and make your experience more comfortable. Consider including items that promote relaxation, nourishment, and entertainment, such as:

• Electronics and headphones for music or movies
• Books, magazines, or journals for personal reflection
• Activity books (like coloring books or crossword puzzles)
• A cozy blanket or pillow
• Headwear options like hats or scarves
• A reusable water bottle to stay hydrated
• Healthy snacks that you enjoy
• Nausea relief items, including ginger chews or mints
• Personal care products, such as fragrance-free lotion and lip balm

Remember that your care team at EPCCC is here to support you every step of the way. Don’t hesitate to discuss your concerns and questions with your oncologist or cancer care team so you can prepare in the best way possible for your unique situation.

Hodgkin lymphoma (HL) can present with various signs and symptoms, which may evolve over time. Common symptoms include:

1. Swollen Lymph Nodes: The most prominent sign is usually painless swelling of lymph nodes in the neck, armpit, or groin. These nodes may feel firm or rubbery.
2. Fever: Patients may experience persistent fevers without an infectious cause, often referred to as “B symptoms.”
3. Night Sweats: Drenching night sweats that can soak clothing and bedding, often severe and uncomfortable.
4. Unexplained Weight Loss: Significant weight loss (more than 10% of body weight) over a short period without changes in diet or exercise.
5. Fatigue: Persistent fatigue or lack of energy that does not improve with rest.
6. Itching: Generalized itching (pruritus) can occur without a rash and may be bothersome.
7. Chest Pain or Cough: If the lymphoma affects areas in the chest, individuals may experience chest pain, persistent cough, or difficulty breathing.
8. Abdominal Pain or Swelling: Involvement of the abdomen may lead to pain or a sense of fullness due to enlarged lymph nodes or spleen.
9. Alcohol-Induced Pain: Some patients report pain in lymph nodes after consuming alcohol, which is quite specific to Hodgkin lymphoma.

Several factors can increase the risk of developing Hodgkin lymphoma:

1. Age: Hodgkin lymphoma is most commonly diagnosed in young adults aged 15-35 and older adults aged 55 and above.
2. Gender: It is more common in males than females.
3. Family History: A family history of Hodgkin lymphoma or other related cancers may increase risk.
4. Weakened Immune System: Individuals with weakened immune systems, such as those with HIV/AIDS or those on immunosuppressive therapy, have an increased risk.
5. Viral Infections: Infections with the Epstein-Barr virus (EBV) and human immunodeficiency virus (HIV) are associated with an elevated risk.
6. Geographic Location: There are geographic variations in HL incidence, with higher rates reported in certain regions.
7. Obesity: Some studies suggest a potential link between obesity and an increased risk of Hodgkin lymphoma.
8. Previous Radiation Therapy: Individuals who received radiation therapy for other cancers, especially during childhood, may have a heightened risk.

The treatment of Hodgkin lymphoma (HL) often depends on the stage of the disease, tumor characteristics, the patient’s age, and overall health. Common treatment options include:

1. Chemotherapy: Chemotherapy is the cornerstone of treatment for Hodgkin lymphoma. Common regimens include ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine), which is effective in most patients.
2. Radiation Therapy: Radiation therapy may be used alone or in combination with chemotherapy, especially for localized disease (early-stage HL). It targets specific areas affected by lymphoma.
3. Stem Cell Transplant: For patients with relapsed or refractory Hodgkin lymphoma, high-dose chemotherapy followed by autologous stem cell transplantation may be considered. This allows for the use of higher doses of chemotherapy to effectively destroy cancer cells.
4. Immunotherapy: Newer targeted therapies, including monoclonal antibodies (like brentuximab vedotin), use the body’s immune system to fight cancer. This option may be used in certain cases of relapsed or refractory HL.
5. Clinical Trials: Participation in clinical trials may provide access to innovative therapies and new treatment approaches that are not yet widely available.
6. Supportive Care: Management of side effects and supportive care to maintain quality of life during treatment are crucial. This may include medication for nausea, pain management, and counseling services.

1. Hodgkin Lymphoma: The overall 5-year survival rate for Hodgkin lymphoma is approximately 87%, with a significant number of patients achieving long-term remission. Cure rates in early-stage HL can be even higher, exceeding 90%with appropriate treatment.
2. Advancements in Treatment: Cutting-edge treatments such as targeted therapies and immunotherapy (including CAR T-cell therapy) have shown promising results. In certain cases of relapsed/refractory NHL, CAR T-cell therapy has achieved response rates surpassing 50%.
3. Chemotherapy Success: First-line chemotherapy regimens for Hodgkin and many types of non-Hodgkin lymphoma, such as R-CHOP (rituximab combined with chemotherapy), lead to high initial response rates, with many patients showing significant reduction or complete disappearance of tumors.
4. Survivorship: Many lymphoma survivors go on to lead healthy, fulfilling lives. Long-term follow-up studies show that most individuals achieve a normal or near-normal quality of life after treatment, especially with supportive care and monitoring.

Treatment Modalities

• Combination Chemotherapy: Most lymphomas are treated with combination chemotherapy, which enhances the effectiveness of treatment and reduces the risk of resistance. Such regimens have improved overall survival rates for various lymphoma types.
• Radiation Therapy: For localized lymphoma, radiation therapy can be highly effective. It often leads to excellent outcomes, especially in early-stage Hodgkin lymphoma, with success rates over 90%.
• Stem Cell Transplants: For patients with relapsed or refractory lymphoma, autologous stem cell transplants can offer a chance of long-term remission. Survival rates post-transplant can be around 50-60%, depending on various factors.

Ongoing Research and Future Prospects

Customized Treatment Approaches: Advances in genetics and molecular biology allow for more personalized treatment approaches, enabling physicians to tailor therapies based on individual patient characteristics and disease profiles.

Non-Hodgkin Lymphoma (NHL) can present with a variety of signs and symptoms, which may vary depending on the subtype of NHL and the areas of the body affected. Common signs and symptoms include:

1. Lymphadenopathy: Swollen lymph nodes, particularly in the neck, armpits, or groin. These may feel rubbery or firm and are often painless.
2. Fever: Persistent fevers without an obvious cause, sometimes with chills.
3. Unexplained Weight Loss: Significant weight loss (more than 10% of body weight) without trying or without an underlying reason.
4. Night Sweats: Drenching night sweats that may soak through clothing and bedding.
5. Fatigue: Chronic fatigue or weakness that doesn’t improve with rest.
6. Abdominal Pain or Swelling: Pain or discomfort in the abdomen, which may also be associated with a swollen abdomen due to enlarged lymph nodes or spleen.
7. Chest Pain: If lymphoma affects the chest area, it can cause chest pain, coughing, or difficulty breathing.
8. Itching: Generalized itching (pruritus) without a rash, which can be quite bothersome.
9. Skin Changes: In some cases, NHL can present with skin rashes, lesions, or lumps.

It’s important to note that these symptoms can be caused by other health conditions as well; experiencing one or more of these symptoms doesn’t necessarily mean an individual has NHL. However, if symptoms persist or worsen, it is advisable to consult a healthcare professional for further evaluation.

Several factors can increase the risk of developing Non Hodgkin lymphoma (NHL):

1. Age: The risk of NHL increases with age, with most cases diagnosed in adults aged 60 and older.
2. Gender: Men are more likely to develop NHL than women.
3. Weakened Immune System: Individuals with weakened immune systems, such as those with HIV/AIDS, have a higher risk of developing NHL. Immunosuppressive treatments (e.g., for organ transplant patients) also increase risk.
4. Autoimmune Diseases: Conditions such as rheumatoid arthritis, lupus, or Sjögren’s syndrome can increase the risk due to chronic inflammation and immune activation.
5. Infections: Certain viral infections, such as the Epstein-Barr virus (EBV), human immunodeficiency virus (HIV), and human T-cell lymphotropic virus (HTLV), have been linked to an increased risk of developing certain types of NHL.
6. Chemical Exposure: Exposure to certain chemicals, particularly pesticides, herbicides, and solvents such as benzene, may be associated with a higher risk of NHL.
7. Family History: A family history of lymphoma or other blood cancers may increase an individual’s risk.
8. Geographic Location: Some studies suggest that living in certain geographic regions with higher pesticide use or specific environmental exposures may contribute to an increased risk.
9. Obesity: Some research indicates that obesity may be a risk factor for developing various types of lymphoma.
10. Previous Radiation Therapy: Individuals who have received radiation therapy for other cancers may have an increased risk of developing NHL later.

1. Chemotherapy:Chemotherapy is often the first-line treatment for many types of NHL. It involves the use of powerful drugs to kill cancer cells or inhibit their growth. Commonly used chemotherapy regimens include:
   • R-CHOP:A combination of rituximab (a monoclonal antibody) with cyclophosphamide, doxorubicin, vincristine, and prednisone.
   • CHOP:Similar to R-CHOP but does not include rituximab.
2. Targeted Therapy: Targeted therapies are designed to specifically attack cancer cells while minimizing damage to normal cells. Some examples include:
   • Rituximab (Rituxan):A monoclonal antibody targeting CD20-positive B-cell lymphomas.
   • Brentuximab Vedotin (Adcetris):A medication that combines an antibody with a chemotherapy drug, used for specific subtypes of NHL.
3. Immunotherapy: Immunotherapy utilizes the body’s immune system to combat cancer cells. It includes therapies such as:
4. CAR T-Cell Therapy:A groundbreaking treatment that involves modifying a patient’s own T-cells to target and destroy lymphoma cells, showing high effectiveness in certain types of aggressive NHL.
5. Nivolumab (Opdivo) and Pembrolizumab (Keytruda):Immune checkpoint inhibitors that help the immune system recognize and attack cancer cells.
6. Radiation Therapy: Radiation therapy may be used to target specific areas of lymphoma, especially for localized disease. It can be effective in combination with chemotherapy for certain patients.
7. Stem Cell Transplant: For patients with high-risk or relapsed NHL, stem cell transplantation (autologous or allogeneic) may be considered. This approach allows for the use of high-dose chemotherapy to treat the lymphoma, followed by transplanting healthy stem cells to restore the bone marrow.
8. Supportive Care: Throughout treatment, supportive care is essential to manage side effects and improve quality of life. This can include anti-nausea medications, pain management, nutritional support, and counseling services.
9. Observation (Watchful Waiting): In some cases of indolent or slow-growing NHL, especially in asymptomatic patients, a strategy of “watchful waiting” may be recommended, where treatment is delayed until symptoms arise or the disease progresses.

Conclusion

Non-Hodgkin Lymphoma comprises a diverse group of diseases, and treatment plans are personalized based on many factors, including the specific lymphoma subtype and the patient’s overall health. Early diagnosis and access to effective therapies greatly enhance treatment success rates. It’s essential for patients to discuss all available treatment options with their healthcare providers to determine the most appropriate approach for their individual situation.

1. Non Hodgkin Lymphoma:The 5-year survival rate for non-Hodgkin lymphoma varies widely based on the specific type and stage but is generally around 72%. For some aggressive subtypes, advances in treatment have improved survival rates markedly.
2. Advancements in Treatment: Cutting-edge treatments such as targeted therapies and immunotherapy (including CAR T-cell therapy) have shown promising results. In certain cases of relapsed/refractory NHL, CAR T-cell therapy has achieved response rates surpassing 50%.
3. Chemotherapy Success: First-line chemotherapy regimens for Hodgkin and many types of non-Hodgkin lymphoma, such as R-CHOP (rituximab combined with chemotherapy), lead to high initial response rates, with many patients showing significant reduction or complete disappearance of tumors.
4. Survivorship: Many lymphoma survivors go on to lead healthy, fulfilling lives. Long-term follow-up studies show that most individuals achieve a normal or near-normal quality of life after treatment, especially with supportive care and monitoring.

Treatment Modalities

• Combination Chemotherapy: Most lymphomas are treated with combination chemotherapy, which enhances the effectiveness of treatment and reduces the risk of resistance. Such regimens have improved overall survival rates for various lymphoma types.
• Radiation Therapy: For localized lymphoma, radiation therapy can be highly effective. It often leads to excellent outcomes, especially in early-stage Hodgkin lymphoma, with success rates over 90%.
• Stem Cell Transplants: For patients with relapsed or refractory lymphoma, autologous stem cell transplants can offer a chance of long-term remission. Survival rates post-transplant can be around 50-60%, depending on various factors.

Ongoing Research and Future Prospects

Customized Treatment Approaches: Advances in genetics and molecular biology allow for more personalized treatment approaches, enabling physicians to tailor therapies based on individual patient characteristics and disease profiles.

1. Transitional Cell Carcinoma (Urothelial Carcinoma): The most common type, originating in the bladder’s inner lining.

2. Squamous Cell Carcinoma: Less common, often linked to irritation and inflammation of the bladder.

3. Adenocarcinoma: A rare form that develops from glandular cells in the bladder.

4. Small Cell Carcinoma: A rare and aggressive type that resembles small cell lung cancer.

1. Medical History and Physical Examination: A healthcare provider will assess symptoms and perform a physical exam.

2. Urinalysis: A urine test can reveal blood (hematuria) or abnormal cells.

3. Cystoscopy: A thin tube with a camera is inserted into the bladder to visually inspect for tumors or abnormalities.

4. Biopsy: If abnormal tissue is found, a biopsy may be conducted during cystoscopy to confirm the presence of cancer.

5. Imaging Tests: CT scans, MRIs, or ultrasounds may be used to evaluate the extent of the disease.

Signs and Symptoms

• Blood in Urine (Hematuria): The most common symptom.
• Frequent Urination: A strong urge to urinate more often than usual.
• Painful Urination: Discomfort or burning sensation while urinating.
• Lower Abdominal Pain: Discomfort in the bladder or pelvic area.
• Back Pain: Pain in the lower back may also occur in advanced stages.

Risk Factors

1. Smoking: The leading risk factor associated with bladder cancer.
2. Chemical Exposure: Contact with certain chemicals, especially in industrial settings.
3. Chronic Irritation: Repeated urinary tract infections or bladder inflammation.
4. Family History: A genetic predisposition can increase risk.
5. Age and Gender: More common in older adults and men.

This information provides a snapshot of bladder cancer, covering essential aspects for better understanding.

• Surgery:
  Transurethral Resection (TURBT): A common procedure to remove tumors.
  Cystectomy: Removal of part or all of the bladder in advanced cases.
• Chemotherapy:
  Used to kill cancer cells or prevent them from growing, either before or after surgery.
• Immunotherapy:
  Treatments that help the immune system recognize and attack cancer cells.
• Radiation Therapy:
  Can be used in conjunction with other treatments or for patients who cannot undergo surgery.
• Targeted Therapy:
  Newer drugs target specific characteristics of cancer cells to block their growth.

AUTHORIZATION REQUIRED: 

• Alignment Health Plan    
• AllCare IPA Merced (HMO/NO DERM)  
• ALLIANCE (CCAH)
• Anthem MediCAL Managed Care Prog.  
• Brand New Day-Universal Care, Inc.- Medicare 
• Calviva Health 
• Community Care IPA
• California Forensic Medical Group, Inc  
• Health Plan of San Joaquin HMO
• Kova Healthcare, Inc. IPA  
• Imperial Health Medical
• MediCAL  
• Central Valley Medical Providers IPA
• Sequoia Health IPA 
• United Healthcare (AARP)
• Sante Community Physicians  
• Tricare TriWest Healthare
• Alliance  
• Western Growers Assurance Trust  
• Central Valley Pace County Medical Services Program 
• Esperanza IPA- Medicare HMO
• Choice Program
• HealthNet CA- First Health Hill Physicians 
• Humana LaSalle Network Management IPA  
• Meritage Medical Network
• Seven Corners 

NO AUTHORIZATION REQUIRED: 

• Aetna
• Anthem
• Blue Cross of CA  
• Blue Shield of CA
• Medicare 
• UMR ACPN Network-America’s Choice PN  
• First Health Network-Cofinity Galaxy Health Network
• HealthSmart 
• CIGNA
• Anthem ACA Plans- Pathway EPO, PPO 
• BS of CA Promise Health Plan
• Medicare
• Railroad Multiplan/PHCS  
• NaphCare NX Health Network LLC d/b/a Valenz Access 
• Provider Network of America (PNOA)
• Wellcare
• WelbeHealth 

• Verify benefits, plan limits, referral, and pre-authorization requirements before your appointment.
• Bring your insurance card(s).
• Notify us of any insurance or personal information changes immediately.
• Understand your financial responsibility for co-pays, deductibles, and non-covered services.

• We verify and review your benefits.
• We help obtain necessary referrals and authorizations.
• We provide cost estimates.
• We inform you about financial assistance options.
• We bill your primary and, if authorized, secondary insurance.
• For Medicare patients, supervising physician info will be included on your claims.
• Our Financial Counselors can provide resources for you to help navigate obtaining traditional insurance coverage 

• Present your current insurance card at each visit.
• Keep us updated on insurance info.
• Pay co-pays at the time of service.
• Cover any balances remaining after insurance payments.

As you process this life-changing news, know that El Portal Cancer Centers and our staff stand with you, offering strength and compassionate encouragement as you navigate treatment and beyond. You can count on us to help you regain control and move forward with hope and resilience. Together, we are dedicated to supporting you through every phase of your cancer journey.

After a breast cancer diagnosis, here are several important steps to follow to ensure comprehensive care and support. This outline will help you to navigate what happens next.

1. Consultation: Meet with your oncologist and other specialists to discuss the diagnosis, staging of the cancer, and available treatment options. This may include surgical options, radiation therapy, chemotherapy, targeted therapy, or hormone therapy.

2. Treatment Planning: Work with your medical team to develop a personalized treatment plan based on the type of breast cancer, its stage, and your overall health. This plan should outline the proposed treatments, timelines, and potential side effects.

3. Second Opinion: Consider seeking a second opinion from another healthcare professional or cancer center. This can provide additional perspectives on your treatment options and help you feel more confident in your decisions.

4. Learn About Your Diagnosis: Educate yourself about your specific type of breast cancer, treatment options, and potential side effects. Understanding your condition can empower you to make informed decisions.

5. Emotional Support: Reach out for emotional support from family, friends, or support groups. Talking with others who have gone through similar experiences can help you cope with the emotional challenges of a cancer diagnosis.

6. Nutrition and Wellness: Focus on maintaining a healthy diet and lifestyle. A nutritionist may help you develop a meal plan that supports your treatment and overall health. Incorporating physical activity, if possible, can also be beneficial.

7. Regular Monitoring and Follow-Up: Schedule regular follow-up appointments with your healthcare team to monitor your progress and manage any side effects of treatment. Follow-up care is important for detecting any potential recurrence of cancer.

8. Explore Support Services: Many hospitals and cancer centers offer resources such as counseling, financial assistance, and educational programs. Explore these services to help navigate your journey.

9. Consider Long-Term Planning: Discuss potential long-term effects of treatment with your doctor, including hormonal changes, fertility issues, and menopause. Planning for these aspects can help you prepare emotionally and physically.

10. Celebrate Milestones: Acknowledge and celebrate milestones along your journey, whether it’s completing treatment, receiving positive test results, or simply reaching personal goals.

Every person’s journey is unique, and it’s essential to communicate openly with your healthcare team and loved ones throughout the process. Prioritize self-care, seek support, and remember that it’s okay to ask for help when needed.

Breast cancer screening guidelines are designed to help detect breast cancer early when it is most treatable. Here’s an overview of the current recommendations for both women and men.

Breast Cancer Screening Guidelines for Women

Age to Start Screening:

• Ages 40 – 44:Women should have the option to start annual screening mammograms if they choose to do so.
• Ages 45 – 54:Annual mammograms are recommended.
• Ages 55 and Older:Women can transition to biennial (every two years) mammograms, or they may continue annual screening if they prefer. Screening should continue as long as a woman is in good health and has a life expectancy of 10 years or more.
• Clinical Breast Exam: Clinical breast exams by a healthcare provider are no longer universally recommended as part of routine screening but may still be performed based on individual patient needs.

Breast Self-Exam: Regular breast self-exams are not recommended as a primary screening tool, but being familiar with one’s breast tissue can help women notice any changes.

For Women at Higher Risk: Women with a family history of breast cancer, genetic mutations (like BRCA1 or BRCA2), or other risk factors may need to begin screening earlier (often at age 30) and consider additional imaging tests like MRI.

Breast Cancer Screening Guidelines for Men

General Recommendations: Routine screening mammograms are not recommended for men. However, awareness of breast changes is essential, as men can develop breast cancer, though it is rare.

Awareness and Self-Exams: Men should also be aware of their breast tissue and report any changes, such as lumps or changes in appearance, to a healthcare provider.

For Men at Higher Risk: Men with significant family histories of breast cancer or genetic predispositions may require more frequent monitoring and potentially earlier screening.

Summary

Breast cancer screening is crucial for early detection and successful treatment. Women should begin regular screening based on established age guidelines, while men should remain vigilant about changes in their breast tissue, especially if they are at higher risk. It’s essential for individuals to have open discussions with their healthcare providers about personal risk factors and the most appropriate screening protocols for their circumstances.

Lung cancer screening is designed to detect the disease in its early stages when treatment is most effective. Here are the current guidelines for lung cancer screening, focusing primarily on individuals at high risk.

Screening Recommendations

High-Risk Individuals:

• Age:Annual screening is recommended for adults aged 50 to 80
• Smoking History: Individuals with a 30 pack-year smoking history (smoking one pack per day for 30 years, or two packs per day for 15 years) or a comparable history of smoking need to be screened. This includes current smokers and those who have quit within the last 15 years.
• Risk Factors: Individuals with other risk factors, such as a significant family history of lung cancer or exposure to certain carcinogens (like asbestos), may also be considered for screening.
• Screening Method: The primary method recommended for lung cancer screening is low-dose computed tomography (LDCT). This technology uses lower doses of radiation than traditional CT scans and is effective in identifying early-stage lung cancers.
• Screening Intervals: If no cancer is detected, individuals should continue to receive annual LDCT screenings as long as they meet the high-risk criteria.
• Discontinuing Screening: Screening should be discontinued when an individual has not smoked for 15 yearsor if they are no longer in good health and unable to undergo treatment for lung cancer.

Importance of Screening
Lung cancer is often diagnosed at a late stage, which can impact treatment success and survival rates. Early detection through appropriate screening can significantly improve outcomes for high-risk individuals.

Discussing Screening with a Healthcare Provider

It’s essential for individuals who meet the high-risk criteria to have discussions with their healthcare providers about the benefits and risks of lung cancer screening. This conversation should also encompass personal health history and any additional risk factors that may influence the recommendation for screening.

Regular consultations and follow-up evaluations can help ensure that individuals remain informed and proactive about their lung health.

Cervical cancer screening is crucial for early detection and prevention of the disease. Here’s an overview of the current recommendations for cervical cancer screening:

General Recommendations

Age to Start Screening:

• Women Ages 21 to 29: Begin screening with a Pap test(cervical cytology) every 3 years.
• Women Ages 30 to 65: There are two screening options:
• Pap Test Alone: Every 3 years.
• HPV Test Alone: Every 5 years (preferred option).
• Pap and HPV Co-Testing: Every 5 years.

Age to Stop Screening: Women may stop cervical cancer screening at age 65if they have had regular screening with negative results in the past and are not at high risk for cervical cancer.

Frequency of Screening: Screening intervals can vary based on age, past medical history, and the type of test being used. Women should consult with their healthcare provider to determine the best schedule for screening.

Special Considerations

Women with Higher Risk: Women who have a history of cervical cancer, high-grade cervical lesions, or are immunocompromised (e.g., those with HIV) may require more frequent screening, starting earlier and continuing beyond age 65.

Post-Hysterectomy: Women who have undergone a hysterectomy (surgical removal of the uterus and cervix) for non-cancerous reasons typically do not need cervical cancer screening, unless the surgery was done for cervical cancer or pre-cancer.

Vaccination: The HPV vaccine can significantly reduce the risk of cervical cancer. Vaccination is recommended for preteens, but it is also beneficial for young adults who have not been vaccinated.

Importance of Screening

Cervical cancer screening has dramatically reduced cervical cancer rates and mortality through early detection and the ability to identify precancerous changes. Women are encouraged to maintain regular screenings and follow the guidelines to ensure their health and well-being.

Conclusion

Regular cervical cancer screening is an essential part of preventive healthcare for women. Open discussions with healthcare providers can help assess individual risk factors and tailor screening schedules appropriately.

Several screening tests are available, ranging from convenient at-home options to more comprehensive procedures performed at healthcare facilities. Your doctor will work with you to select the best method based on your age and family history.

At-Home Screening Options

These tests allow you to screen in the comfort of your home without extensive preparation, though they may carry risks of false positives.

1. At-Home Testing for Colorectal Cancer: If you are under 50, your physician may recommend at-home testing before scheduling a colonoscopy. This approach lets you complete the test without a day of prior colon preparation. However, it’s essential to note that these tests may overlook some polyps and cancers.
2. Stool DNA Test: Advances in at-home stool testing, such as Cologuard, have made it easier to conduct Fecal Immunochemical Tests (FIT). This simple test checks for blood and genetic changes without requiring extensive dietary changes.
3. Guaiac-based Fecal Occult Blood Test (gFBOT): Another home test prescribed by your doctor, gFBOT identifies hidden blood in the stool. If blood is detected, follow-up with a colonoscopy is typically necessary.

Screening at Healthcare Facilities

Screening procedures conducted in medical facilities are often the most accurate and valuable in colorectal cancer detection, allowing for the immediate removal of any suspicious polyps.

• Standard Colonoscopy: In this procedure, a colonoscope provides detailed images of your colon and allows for tissue removal if abnormalities are found. Proper preparation and sedation are necessary for successful outcomes, and studies show that regular colonoscopies can significantly reduce colorectal cancer mortality rates.
• Virtual Colonoscopy: Utilizing CT imaging to view your colon, this test usually does not require sedation but does involve bowel preparation. If potential issues arise, a standard colonoscopy may follow for confirmation.

When Should You Be Screened for Colorectal Cancer?

The American Cancer Society (ACS) has recently lowered the recommended screening age from 50 to 45 due to rising colorectal cancer rates among younger adults. Contributing factors may include dietary choices, physical inactivity, and obesity.
Recommended screening frequencies vary based on risk levels:

• Average Risk: Adults with no family history of colorectal cancer should undergo screenings every ten years.
• High Risk: Those with a family history, previous inflammatory diseases, or prior radiation exposure to the pelvic area should start screenings earlier and have them more frequently.

Lung cancer screening is designed to detect the disease in its early stages when treatment is most effective. Here are the current guidelines for lung cancer screening, focusing primarily on individuals at high risk.

Screening Recommendations

High-Risk Individuals:

• Age:Annual screening is recommended for adults aged 50 to 80
• Smoking History: Individuals with a 30 pack-year smoking history (smoking one pack per day for 30 years, or two packs per day for 15 years) or a comparable history of smoking need to be screened. This includes current smokers and those who have quit within the last 15 years.
• Risk Factors: Individuals with other risk factors, such as a significant family history of lung cancer or exposure to certain carcinogens (like asbestos), may also be considered for screening.
• Screening Method: The primary method recommended for lung cancer screening is low-dose computed tomography (LDCT). This technology uses lower doses of radiation than traditional CT scans and is effective in identifying early-stage lung cancers.
• Screening Intervals: If no cancer is detected, individuals should continue to receive annual LDCT screenings as long as they meet the high-risk criteria.
• Discontinuing Screening: Screening should be discontinued when an individual has not smoked for 15 yearsor if they are no longer in good health and unable to undergo treatment for lung cancer.

Importance of Screening
Lung cancer is often diagnosed at a late stage, which can impact treatment success and survival rates. Early detection through appropriate screening can significantly improve outcomes for high-risk individuals.

Discussing Screening with a Healthcare Provider

It’s essential for individuals who meet the high-risk criteria to have discussions with their healthcare providers about the benefits and risks of lung cancer screening. This conversation should also encompass personal health history and any additional risk factors that may influence the recommendation for screening.

Regular consultations and follow-up evaluations can help ensure that individuals remain informed and proactive about their lung health.

Prostate cancer screening guidelines are designed to help identify the disease in its early stages when it can be treated more effectively. Here’s an overview of the current recommendations:

Screening Recommendations

Age to Start Screening:

• Men at Average Risk:Screening for prostate cancer using the prostate-specific antigen (PSA) test is generally recommended to begin at age 50.
• Men at High Risk:For those at higher risk, including African American men or those with a family history of prostate cancer, screening may begin earlier, at age 45.
• Risk Factors:

Family History:A strong family history of prostate cancer (e.g., a father or brother diagnosed with the disease).

Ethnicity: African American men are at a higher risk for developing prostate cancer.

Genetic Factors: Inherited genetic mutations, such as BRCA1 or BRCA2, can increase risk.

Discussion of Screening: It is crucial for men to have an informed discussion with their healthcare provider about the risks and benefits of prostate cancer screening, including the potential for false positives and overdiagnosis. This discussion should encompass personal risk factors and overall health status.

Shared decision-making is emphasized to ensure that individuals understand the implications of screening and can make choices that align with their values and preferences.

Screening Methods:

• PSA Test:A blood test measuring the level of prostate-specific antigen. Elevated levels may indicate prostate cancer or other prostate conditions.
• Digital Rectal Examination (DRE):Although less commonly used as a standalone screening tool, a DRE may be performed alongside the PSA test to check for abnormalities in the prostate.

Follow-Up: If screening results indicate elevated PSA levels or if a DRE suggests abnormalities, further evaluation, including a biopsy, may be recommended to confirm the presence of prostate cancer.

Discontinuing Screening: For men over age 70or those with less than a 10-year life expectancy due to other health issues, the benefits of continuing routine screening may not outweigh the risks. Discussions around stopping screening should be had with healthcare providers.

Summary

Prostate cancer screening is an important health consideration for men, particularly those at higher risk. Open communication with healthcare providers can help guide decisions about when to start screening and how to proceed based on individual circumstances.

Pancreatic cancer is often diagnosed at an advanced stage, making early detection challenging. As a result, screening guidelines focus primarily on high-risk individuals rather than the general population. Here’s an overview of current recommendations for pancreatic cancer screening:

General Recommendations

• High-Risk Individuals: Screening for pancreatic cancer is recommended primarily for individuals at high risk due to specific factors:
• Family History: A strong family history of pancreatic cancer or other associated cancers (e.g., breast, ovarian, or colorectal cancer) may heighten risk. Individuals with genetic syndromes, such as BRCA2mutations, Lynch syndrome, or familial atypical multiple-mole melanoma syndrome (FAMMM), are also at increased risk.
• Chronic Pancreatitis:Long-standing inflammation of the pancreas can elevate the risk of developing cancer.
• Age and Testing: For individuals at high risk, screening usually begins between ages 40 and 50, depending on individual risk factors and family history.
• Women with BRCA mutations may start screening at age 50or younger.

Screening Methods

Imaging Tests:

• MRI (Magnetic Resonance Imaging) or Endoscopic Ultrasound (EUS): These imaging techniques are the most commonly used for pancreas cancer screening in high-risk individuals. They provide detailed images of the pancreas and can help identify cysts or tumors.
• Biomarker Testing: Research is ongoing to identify blood markers associated with pancreatic cancer, but as of now, there are no established routine blood tests for screening.

Follow-Up and Risk Management

• Regular Monitoring: Individuals at high risk should undergo regular screening every 1 to 2 years, depending on their healthcare provider’s recommendations and findings from previous screenings.
• Genetic Counseling: For individuals with a strong family history or genetic predisposition, genetic counseling can provide insights and may help guide decision-making regarding screening and preventive measures.

Conclusion

Because of the aggressive nature of pancreatic cancer and its often late-stage diagnosis, screening is primarily targeted at those identified as high risk. If you have concerns about your risk for pancreatic cancer, it’s essential to discuss them with your healthcare provider, who can help assess your risk and establish an appropriate screening plan.

Following your initial consultation with the El Portal team, where your treatment plan is outlined and questions are answered, you’ll be scheduled for a chemotherapy education class. This class will give you essential information about what to anticipate during your treatments, including the duration of appointments, the procedures involved, and resources for addressing questions or side effects after hours.

During this class, you will also meet with a dedicated Patient Financial Counselor who will discuss treatment costs, insurance pre-authorization, and any financial concerns you may have. Once your insurance authorizes your treatment, our office staff will contact you to schedule your first chemotherapy session.

Preparing for Your First Chemotherapy Appointment

Your care team will provide specific instructions for preparing for your first treatment, but in general, preparation is minimal. Drinking plenty of water the day before treatment is recommended, and it is advisable to eat a light meal prior to your appointment. Packing a snack may also help alleviate potential nausea. It’s a good idea to have someone drive you to and from your appointment in case you experience fatigue or nausea afterward.

During your first visit, you will be weighed and have your vital signs checked to ensure it is safe to proceed with chemotherapy. An oncology nurse will insert an IV into your hand or arm, or connect an IV line to your pre-implanted port, if applicable. The chemotherapy drugs will be administered through the IV in a slow, continuous manner. As you receive treatment, you can relax in one of our spacious, light-filled treatment bays equipped with reclining chairs and WiFi access.

Each session may require several hours, so bringing a book or something to watch can make the time more enjoyable. Snacks and water are permitted, and you can make use of the restroom as needed throughout the treatment.

When you’re referred to EPCCC, your medical oncologist and a team of cancer specialists will create a personalized treatment plan tailored to your specific circumstances, considering factors such as:

• Type and grade of your cancer
• Size and location of your tumor
• Sensitivity of surrounding tissues
• Genetic factors
• Family medical history
• Your age, overall health, and previous medical history
• Your treatment goals and preferences

What to Expect During Chemotherapy Treatments

After your initial meeting with your cancer care team to discuss your treatment plan and address any questions, you will be scheduled to attend a chemotherapy education class at El Portal Comprehensive Cancer Centers. This session will provide valuable insights into what you can anticipate from chemotherapy treatment. You will also have the opportunity to meet privately with one of our dedicated cancer financial counselors to discuss treatment costs, insurance coverage, and potential financial assistance.

Your regular chemotherapy treatments will vary based on the specific type of therapy prescribed. Some chemotherapy drugs are given via injection, which is quick, while most are delivered through intravenous infusion, allowing the medication to enter your veins in a slow, continuous manner.

One of the most frequently reported side effects among cancer patients is fatigue. This deep-seated tiredness—often referred to as cancer-related fatigue—can differ significantly from the fatigue experienced by healthy individuals. It can manifest suddenly or gradually, and may not improve with rest. In some cases, fatigue may be compounded by other factors such as anemia and pain. The encouraging news is that this fatigue typically resolves within weeks following the conclusion of treatment.

While side effects will vary by cancer type and individual patient responses, not everyone will experience the same issues. It’s essential to approach this variability with mindfulness and not to expend excessive energy worrying about potential side effects.

Chemotherapy side effects may include:

• Mental fog, often described as “chemo brain,” leading to forgetfulness and difficulty concentrating
• Hair loss
• Easy bruising or bleeding
• Increased susceptibility to infections (bacterial, viral, or fungal)
• Anemia (low red blood cell count)
• Nausea and vomiting
• Loss of appetite
• Constipation and diarrhea
• Pain
• Oral health issues, such as dry mouth, sores, and difficulty swallowing
• Nerve and muscle concerns, including numbness and weakness
• Changes to skin and nails, such as dryness and cracking
• Altered urinary characteristics, affecting color and smell
• Weight loss
• Changes in memory and concentration
• Mood fluctuations
• Alterations in libido and sexual function
• Potential fertility challenges
• Heart-related concerns

In certain cases, chemotherapy may be the sole treatment required. However, it is frequently used in conjunction with other therapies, such as surgery or radiation therapy, to maximize chances of success.

• Neoadjuvant Chemotherapy: Administered before surgery to shrink tumors or halt cancer spread, making surgical procedures less invasive and more effective.
• Concurrent Treatment: Involving chemotherapy or immunotherapy given simultaneously with radiation therapy.
• Adjuvant Chemotherapy: Given after surgery to eliminate any remaining cancer cells, aimed at reducing recurrence risk.

Who Will Oversee Your Chemotherapy?

Your treatment will be overseen by a medical oncologist, a specialist who evaluates your cancer diagnosis and all available treatment options, creating a personalized plan tailored to your needs. As the “quarterback” of your care team at El Portal Comprehensive Cancer Centers, your oncologist will determine chemotherapy’s appropriateness based on several factors, including tumor type, stage, size, and personal considerations.

Your oncologist works alongside a diverse team of healthcare professionals, including radiation oncologists and surgeons, to coordinate your overall care seamlessly. During treatment sessions, a specially trained oncology nurse will administer chemotherapy, monitor your health, address your questions, and assist you in managing any side effects.

Adopting a healthy lifestyle during cancer treatment can help mitigate some side effects and improve your overall well-being. Here are several strategies to consider for managing chemotherapy side effects:

1. Prioritize Rest: Cancer treatment can be exhausting. Make sure to get ample rest, delegate tasks when necessary, and don’t hesitate to ask for help.
2. Stay Active When Possible: While rest is essential, gentle physical activity can enhance energy levels, improve circulation, reduce stress, and maintain muscle strength. Discuss suitable activities with your healthcare provider to find what works best for you.
3. Communicate About Medications: Some medications can interact negatively with cancer treatments. Inform your care team about all the medications you’re taking, including over-the-counter drugs, supplements, and vitamins.
4. Care for Your Skin: If you experience dryness or irritation from treatment, use gentle skincare products. Warm baths with baby oil and fragrance-free lotions can provide relief. Protect your skin from extreme temperatures and stay hydrated.
5. Recognize Your Emotions: The emotional toll of cancer treatment is significant. Feelings of anxiety, anger, sadness, or isolation are common. Engaging with support groups, whether in-person or online, can provide valuable connection and understanding. At El Portal Comprehensive Cancer Centers (EPCCC), we offer resources to help you cope with the emotional aspects of treatment, including support groups and access to licensed clinical oncology social workers. If you find your feelings overwhelming, be sure to discuss them with your care team.

Thanks to recent developments in treatment, many patients find that the severity of chemotherapy side effects has diminished over the years. New medications are also available to help manage side effects, but occasionally, these medications may bring their own challenges.

In certain cases, side effects may signal more serious complications. If you experience any of the following worsening symptoms, please reach out to your care team at EPCCC for guidance (unless experiencing a life-threatening emergency). Our board-certified medical oncologists and specially trained nurses are well-equipped to evaluate your symptoms and recommend appropriate interventions.

If you encounter any of the following issues, our medical professionals are available 24/7 to assist:

• Fever of 100.4°F (38°C) or higher
• Unexplained bruising or bleeding
• Severe rashes or itching
• Swelling in the mouth or throat, along with mouth sores or trouble swallowing
• Swelling in the neck, shoulder, arms, or legs, especially if asymmetrical
• Intense chills
• Unmanaged pain at injection or catheter sites
• Unusual pain, including severe headaches
• Difficulty breathing (immediate emergency care is needed)
• Persistent diarrhea or vomiting
• Blood in stool or urine
• Severe fatigue
• Burning sensation during urination, with lower back pain (potential UTI)
• Productive cough with colored sputum
• Unresolved diarrhea, constipation, nausea, or vomiting
• Dizziness or lightheaded
• Numbness, tingling (feeling of pins and needles) of hands and/or feet

Dr. Mahmoudieh has been a vital member of El Portal Comprehensive Cancer Centers since 2008, bringing over a decade of dedicated experience to patient care. Before joining our team, he served as the Director of the Prostate Brachytherapy Program at Kaiser Permanente in Sacramento and Roseville, demonstrating his leadership in advanced cancer treatments.

He earned his medical degree from the Albert Szent-Györgyi School of Medicine in Szeged, Hungary, in 1996. With a strong interest in treating head, neck, and breast cancers, Dr. Mahmoudieh specializes in cutting-edge techniques such as Image-Guided Radiation Therapy (IGRT) and Intensity-Modulated Radiation Therapy (IMRT). His expertise extends to treating cancers of the head and neck, lung, gastrointestinal tract, and prostate.

A committed professional, Dr. Mahmoudieh is a member of the American Society for Therapeutic Radiology and Oncology (ASTRO), reflecting his engagement with ongoing developments in cancer treatment and research. His compassionate approach and advanced skill set ensure that each patient receives personalized, state-of-the-art care.

Outside of his professional life, Dr. Mahmoudieh enjoys traveling with his son and daughter, as well as reading and playing racquetball, embracing a balanced and active lifestyle. His dedication to both his patients and his personal passions makes him a trusted partner in your journey toward health.

Dr. Elhanafy is a highly respected Associate Professor of Medical Physics and serves as the Chief Medical Physicist at El Portal Comprehensive Cancer Centers since July 2013. He earned his Ph.D. in Medical Physics from the University of Wisconsin, Madison—where he began his foundational training and completed his thesis—in 2013, building on his initial joining of the university in 1999.

 With specialized training in advanced radiation oncology techniques—such as Intensity-Modulated Radiation Therapy (IMRT), High-Dose Rate Brachytherapy (HDR), Stereotactic Radiosurgery (SRS), Total Body Irradiation (TBI), Quality Assurance, and Radiobiology—Dr. Elhanafy brings a wealth of expertise to patient care. His dedication to the field is evident through numerous published research articles, as well as awards recognizing his leadership in organizing conferences, training sessions, lectures, and workshops.

Beyond his impressive credentials, Dr. Elhanafy is deeply committed to advancing medical physics and ensuring the best possible outcomes for his patients. His compassionate approach, combined with his extensive knowledge, makes him a trusted partner in your cancer care journey.

Outside of his professional pursuits, he values spending quality time with his family, reflecting his genuine care and balance in life.

Dr. Ahuja is a distinguished, board-certified Medical Oncologist with extensive training in medical hematology. He has refined his expertise at renowned institutions such as Tata Memorial Hospital, UCLA School of Medicine, and Roswell Park, under the mentorship of esteemed hematologists including Dr. S.H. Advani, Dr. Michael Caligiuri, and Dr. M.J. Cline.

With over 25 years of experience in both hematology and oncology, Dr. Ahuja offers a deep well of knowledge and a compassionate approach to patient care at El Portal Cancer Center. His dedication to advancing the field is reflected through active membership in prestigious professional organizations, including the American Society of Hematology, the American Society of Clinical Oncology, the European Society of Medical Oncology, and the Indian Society of Medical and Pediatric Oncology.

A passionate researcher, Dr. Ahuja has contributed significantly to ongoing scientific advancements—serving on the NRG Breast Committee and the Rare Subtype Committee, and acting as Principal Investigator for the “CROWN” NCORP study. His commitment to clinical excellence and groundbreaking research underscores his dedication to improving outcomes for his patients.

Outside of his professional pursuits, Dr. Ahuja values spending quality time with his family, and enjoys hiking and traveling, embracing life outside the clinic with the same dedication he brings to his medical practice. His compassionate nature and extensive experience make him a trusted partner in your cancer care journey.

Dr. Crain is a highly experienced and board-certified Medical Oncologist and Hematologist with over 45 years of dedicated service in the medical field. Throughout his distinguished career, he has established himself as a leading expert in the diagnosis, treatment, and prevention of various cancers and blood disorders.

He earned his medical degree from the University of Illinois College of Medicine in 1977 and is actively affiliated with esteemed institutions, including Adventist Health St. Helena. Dr. Crain’s extensive experience spans a broad range of conditions, including small intestine and colorectal cancers, breast cancer, prostate cancer, anemia, leukemia, and lymphoma.

Beyond his clinical expertise, Dr. Crain is deeply committed to advancing medical research and improving patient care. His approach to treatment is rooted in compassion and a thorough understanding of complex medical conditions, ensuring each patient receives personalized, comprehensive care.

Recognized for his empathetic nature and unwavering dedication, Dr. Crain strives to achieve the best possible outcomes for his patients and foster a trusting, supportive environment. His lifelong commitment to the fields of oncology and hematology reflects his passion for making a meaningful difference in his patients’ lives.

Michael Kangas serves as the Director of Oncology and Diagnostic Imaging, where he spearheads initiatives that enhance revenue, profitability, productivity, and patient satisfaction within an underserved area. His leadership is instrumental in developing and guiding a highly skilled team of healthcare professionals across multiple clinics, providing comprehensive cancer care and diagnostic imaging services utilizing the most advanced technology. Michael’s commitment is rooted in delivering personalized, high-quality care to each patient, ensuring they receive the support they need throughout their journey.

With extensive expertise in Health Information Management, Electronic Medical Records (EMR), Radiation Therapy, Radiation Oncology, Clinical Operations, Healthcare Compliance, and Regulatory Standards, Michael ensures that all services meet the highest industry standards. He also focuses on monitoring performance, healthcare marketing, and supervisory skills to foster a collaborative, efficient, and patient-centered environment.

In addition to his clinical leadership, Michael actively volunteers with the Merced Cancer Society Foundation as its Executive Director. In this role, he oversees key operational and administrative functions to advance the foundation’s mission of positively impacting residents in the Central Valley. His efforts include community outreach, organizing fundraising events, and leading initiatives to expand the foundation’s support and resources for local cancer patients.

Michael’s dedication to improving healthcare and strengthening community ties highlights his unwavering commitment to healing, hope, and making a meaningful difference in the lives of those he serves.